Attendee List released for European Pharmaceutical Pricing and Reimbursement

SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on the 5-6 October 2015 in London, will address market access challenges and details how to overcome them with case studies from MSD, Sanofi, GSK and more.
By: SMi Group
 
 
European Pharmaceutical Pricing and Reimbursement
European Pharmaceutical Pricing and Reimbursement
LONDON - Sept. 15, 2015 - PRLog -- In just 3 weeks, SMi will open its doors to the 21st annual European Pharmaceutical Pricing & Reimbursement conference. The two-day event will provide the ideal platform for payers and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharma companies with an invaluable insight into the decision making processes and approaches of vital stakeholders . Furthermore, the conference programme will help further your understanding and enable you to develop best practice approaches to complex market access challenges - with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications through case studies presented by GSK, Sanofi, MSD and many more.

Featured speakers include:
• Leslie Galloway, Chairman, Ethical Medicines Industry Group
• Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs
• Janice Haigh, Practice Leader Market Access, Quintiles
• David Watson, Director of Pricing & Reimbursement, ABPI
• Ken Walsh, Head of Emerging Markets Pricing, GSK
• Toros Sahin, Head of Market Access & Health Economics, Sanofi
• Alexander Roediger, Director European Union Affairs, MSD
• Eric Low, CEO, Myeloma UK
• Maggie Dolan, Regional Pharmacy Procurement Specialist, NHS Commercial Solutions

To view the full speaker line-up and two-day conference programme, visit http://www.smi-online.co.uk/2015europricing1.asp

Benefits of attending:
• The impact of Biosimilars and Orphan Drugs on the the market with case studies from MSD and Quintiles
• Tiered pricing options with a case study from GSK
• Case studies in Reforms with Sanofi sharing their recent experience
• New models for European reimbursement
• Health Technology Assessment policies
• Changes in UK P&R policy following the UK elections with presentations from industry bodies such as EMIG and the ABPI

Plus, don't miss the interactive post-conference workshop on:
HTA Uncovered
Workshop Leaders: Anke Van Engen, Principal - Advisory Services & Janice Haigh, Practice Leader - Market Access, Quintiles
08:30am - 12.30pm | 7th October 2015, London, UK

Contact
SMi Group
vtrinh@smi-online.co.uk
+44 (0) 20 7827 6140
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Pharma, Market Access, Health Economics
Industry:Biotech
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share